Access Program Information
This is an expanded access treatment protocol designed to provide a topical cream treatment
option to military health care beneficiaries with parasitologically confirmed uncomplicated
Cutaneous Leishmaniasis.
U.S. Army Medical Research and Materiel Command – Leishmaniasis, Cutaneous
Rare Disease: